Successful treatment of severe complicated measles with non-specific transfer factor

Severe complicated measles has a high mortality rate and no specific treatment. Ten patients with complicated measles - 9 infants with respiratory failure and a 15 year old boy with encephalitis - received immunotherapy with Non-specific Transfer Factor (NTF). The patients had variable degrees of un...

Full description

Saved in:
Bibliographic Details
Published inIn vivo (Athens) Vol. 8; no. 4; p. 555
Main Authors Ferrer-Argote, V E, Romero-Cabello, R, Hernández-Mendoza, L, Arista-Viveros, A, Rojo-Medina, J, Balseca-Olivera, F, Fierro, M, Gonzalez-Constandse, R
Format Journal Article
LanguageEnglish
Published Greece 01.07.1994
Subjects
Adolescent
Bacterial Infections - complications
Candidiasis, Oral - complications
Chickenpox - complications
Child, Preschool
Encephalitis, Viral - therapy
Encephalitis, Viral - virology
Female
Humans
Immunity, Cellular
Immunotherapy
Infant
Male
Measles - complications
Measles - therapy
Meningoencephalitis - therapy
Meningoencephalitis - virology
Nutrition Disorders - complications
Respiratory Insufficiency - therapy
Respiratory Insufficiency - virology
Transfer Factor - therapeutic use
Online AccessGet more information

Cover

More Information
Summary:Severe complicated measles has a high mortality rate and no specific treatment. Ten patients with complicated measles - 9 infants with respiratory failure and a 15 year old boy with encephalitis - received immunotherapy with Non-specific Transfer Factor (NTF). The patients had variable degrees of undernourishment and were severely ill when immunotherapy was started. 8/9 cases with respiratory failure were cured. One died of bronchoaspiration while recovering from the measles. The case with encephalitis showed no neurological sequelae two weeks after receiving the last dose of NTF. Treatment of complicated measles with NTF in these patients seemed very effective and deserves further trial.
ISSN:0258-851X